Linkage of calpain 10 to type 2 diabetes: the biological rationale.

The follow-up studies to the original report of association of variation at calpain 10 (CAPN10) with type 2 diabetes in the Mexican-American population of Starr County, Texas, encompass a broad range of science. There are association studies on genetic variation at CAPN10 in different human populations over a range of phenotypes related to type 2 diabetes, physiological studies on the biological functions of calpain proteases, and evolutionary studies on CAPN10 and the NIDDM1 region. We review here the studies published to date on CAPN10, as well as the latest findings from positional cloning studies on a number of other complex disorders. Collectively, these studies provide perspective on the challenges of moving from the linkage mapping and positional cloning studies on which we have been focused to an understanding of the biology shaping the relationship of genotype to phenotype at loci influencing susceptibility to complex disorders like type 2 diabetes.

[1]  M. Igarashi,et al.  Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. , 2002, Diabetes research and clinical practice.

[2]  L. Real,et al.  Comment: CAPN10 alleles are associated with polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  D. Moczulski,et al.  Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. , 2002, European journal of endocrinology.

[4]  T. Frayling,et al.  Association of the calpain-10 gene with microvascular function , 2002, Diabetologia.

[5]  Steuart Rorke,et al.  Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness , 2002, Nature.

[6]  T. Frayling,et al.  Variation in the calpain-10 gene affects blood glucose levels in the British population. , 2002, Diabetes.

[7]  T. Hansen,et al.  Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. , 2002, Diabetes.

[8]  M. Stumvoll,et al.  Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. , 2001, Diabetes.

[9]  L. Groop,et al.  Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cells , 2002, Diabetologia.

[10]  K. Huse,et al.  Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells. , 2002, The Journal of clinical endocrinology and metabolism.

[12]  Jon D. McAuliffe,et al.  Phylogenetic Shadowing of Primate Sequences to Find Functional Regions of the Human Genome , 2003, Science.

[13]  Alan E. Jackson,et al.  Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. , 2002, Diabetes.

[14]  E. Boerwinkle,et al.  SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. , 2002, Diabetes.

[15]  Judy H. Cho,et al.  [Letters to Nature] , 1975, Nature.

[16]  C. Bogardus,et al.  A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. , 2000, The Journal of clinical investigation.

[17]  D. Postma,et al.  Association of ADAM33 with asthma and associated phenotypes in ethnically diverse populations. , 2002 .

[18]  B. Zinman,et al.  Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree. , 2001, Diabetes care.

[19]  M. McCarthy,et al.  Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.

[20]  S. Fisher,et al.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.

[21]  C. Hanis,et al.  Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. , 2002, The Journal of clinical endocrinology and metabolism.

[22]  R. Straub,et al.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.

[23]  H. Tsai,et al.  Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. , 2001, American journal of human genetics.

[24]  Kaisa Silander,et al.  Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. , 2002, Diabetes.

[25]  J. Takeda,et al.  Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese. , 2003, The Journal of clinical endocrinology and metabolism.

[26]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[27]  Margot Albus,et al.  Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. , 2003, American journal of human genetics.

[28]  S. Julius,et al.  Type II Diabetes, Essential Hypertension, and Obesity as "Syndromes of Impaired Genetic Homeostasis": The "Thrifty Genotype" Hypothesis Enters the 21st Century , 2015, Perspectives in biology and medicine.

[29]  Michael Stumvoll,et al.  Assessing the shape of the glucose curve during an oral glucose tolerance test. , 2003, Diabetes care.

[30]  Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.

[31]  C. Lindgren,et al.  Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. , 2002, Diabetes.

[32]  J. L. San Millán,et al.  Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism. , 2002, Fertility and sterility.

[33]  J. Hebebrand,et al.  No evidence for involvement of the calpain-10 gene 'high-risk' haplotype combination for non-insulin-dependent diabetes mellitus in early onset obesity. , 2002, Molecular genetics and metabolism.

[34]  Kari Stefansson,et al.  Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. , 2003, American journal of human genetics.

[35]  K. Kidd,et al.  Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus. , 2002, American journal of human genetics.

[36]  Tom H. Lindner,et al.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus , 2000, Nature Genetics.

[37]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[38]  J. Neel.  Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? , 1962, American journal of human genetics.

[39]  N. Cox,et al.  Calpains play a role in insulin secretion and action. , 2001, Diabetes.

[40]  S. Targan,et al.  A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. , 2003, American journal of human genetics.

[41]  M. McCarthy,et al.  Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. , 2001, American journal of human genetics.

[42]  Bert Vogelstein,et al.  Allelic Variation in Human Gene Expression , 2002, Science.